Friends, The day before Thanksgiving is a busy one for me, and I imagine, for you too. But before I turn my attention to holiday prep, I wanted to sit down and write this email to you, and everyone who supports OCRA. THANK YOU. It’s hard to overstate the deep gratitude I feel when I … Continued
(November 25, 2019) This Giving Tuesday, we need your help to make a big impact. For the 22,000 American women diagnosed with ovarian cancer every year, and the 200,000 living with this disease, we’re asking you to join us in #GivingTeal. Here’s how you can help. Be an OCRA Holiday Hero Spread the word and … Continued
(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct chromosome segregation when the cells divide. Specifically, ARID1A controls expression of another protein called STAG1 that is required to keep chromosome ends together. When ARID1A … Continued
Hollywood’s biggest stars have donated fabulous pieces from their own closets in support of ovarian cancer cures. Bidding ends November 10th!
That’s a wrap on #OCRAStyleLab, and what an evening it was for ovarian cancer awareness! (November 6, 2019) Our sincere gratitude to our amazing hosts Maggie Gyllenhaal and Kate Mara, the fabulous En Vogue, media partner InStyle and all the incredible supporters who joined us for this meaningful night to shine a spotlight on ovarian … Continued
(November 6, 2019) A recent research review conducted by a team at the University of Colorado Anschutz, and published this month by the American College of Obstetrics and Gynecology, found that use of an intrauterine device (IUD) was associated with a lower risk of ovarian cancer. Through a systematic literature review and meta-analysis, researchers found … Continued
In an effort to further understand disease initiation and progression, OCRA grantee Dr. Sumegha Mitra, along with colleagues at Indiana University, conducted research which revealed key changes in gene expression occurring during the initiation and early metastasis of ovarian cancer. Dr. Mitra and colleagues identified targets and pathways which can be explored in the future … Continued
(October 28, 2019) Newk’s Cares, the ovarian cancer awareness movement and national campaign founded by fast-casual restaurant Newk’s Eatery, has reached monumental heights! Celebrating its sixth year, Newk’s Cares raised more than $400,000 in September—their largest total to date to support OCRA—and has now surpassed $1.4M raised for ovarian cancer research! Newk’s Cares honors the … Continued
We need your help to strengthen critical gynecologic cancer education and awareness programs. (October 16, 2019) Recently, Rep. Rosa DeLauro (D-CT)—leader of the Congressional Ovarian Cancer Caucus and an ovarian cancer survivor herself—introduced HR 4560, legislation to reauthorize Johanna’s Law, also known as The Gynecologic Cancer Education and Awareness Act. Johanna’s Law supports a variety … Continued
(October 10, 2019) On September 19, fashion and inspiration for ovarian cancer cures hit the runway at OCRA’s first annual Hope Fashion Show in Dallas. Over 150 guests gathered for a special evening featuring the latest looks, plus passed appetizers, specialty cocktails, music, swag bags and a silent auction, all to benefit ovarian cancer research … Continued
(October 7, 2019) Published recently in the New England Journal of Medicine, a group of investigators led by OCRA Scientific Advisory Committee member Dr. Robert Coleman found an innovative combination therapy to significantly increase progression-free survival (PFS). In this phase III clinical trial, patients with previously untreated advanced-stage ovarian cancer received veliparib administered simultaneously with … Continued
(September 19, 2019) While harnessing the immune system has resulted in strong responses for a subset of cancer patients, the majority of patients have remained unresponsive to this approach. In order to enable ovarian cancer patients to benefit from immunotherapy, Dr. Michael Goldberg’s research sought to understand how standard-of-care chemotherapy influences immune cells around the … Continued
Get email updates about research news, action alerts, and ways to join the fight.
